The SARS-CoV-2 IgG II Quant assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative and quantitative determination of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Alinity and ARCHITECT i Systems. The SARS-CoV-2 IgG II Quant assay is to be used as an aid in the diagnosis of SARS-CoV-2 infection in conjunction with clinical presentation and other laboratory tests.
- An aid in evaluating immune status of infected individuals
- Monitor antibody response in individuals that have received the COVID-19 vaccine
- Quantitatively measuring IgG antibodies against the spike receptor-binding domain (RBD) of SARS-CoV-2
The SARS-CoV-2 IgG II Quant Kit for Detecting SARS-CoV-2 is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy the SARS-CoV-2 IgG II Quant Kit for Detecting SARS-CoV-2 for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the SARS-CoV-2 IgG II Quant Kit for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the SARS-CoV-2 IgG II Quant Kit for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.
